Previous Investigations
Archive
Congress Reignites Asbestos Scare with Ban on Aggregates'Extreme inequalities' in mesothelioma drug access
in this section: Lilly Cancer Drug Works in Japanese | 'Inequities' in cancer drug access | NICE says no again to Lilly's Alimta but backs Elan's Tysabri | Pharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R ... | Cancer patients in limbo over drug | Firm loses lung cancer drug appeal | You pay now or die early
|
